Multiple Sclerosis Part 2: Advanced Imaging and Emerging Techniques

Area of Science:

• Neuroimaging
• Neurology
• Biomarker Discovery

Background:

• Multiple sclerosis (MS) is a chronic neurological disease.
• Current diagnostic and prognostic tools for MS have limitations.
• Identifying new imaging biomarkers is crucial for MS management.

Purpose of the Study:

• To investigate advanced imaging methods for multiple sclerosis (MS).
• To identify novel imaging biomarkers for early detection, prognosis prediction, and clinical trial endpoints in MS.
• To understand MS as a global disease affecting brain microstructure.

Main Methods:

• Advanced diffusion imaging
• Magnetization transfer imaging
• Myelin water imaging
• Magnetic resonance spectroscopy
• Glymphatic imaging
• Perfusion imaging

Main Results:

• Advanced imaging techniques probe various aspects of tissue microstructure.
• MS involves microstructural changes in both normal-appearing white and gray matter.
• Global microstructural changes are potentially better predictors of disability than lesion load alone.

Conclusions:

• MS is a global disease with widespread microstructural alterations.
• Advanced imaging biomarkers may offer superior prediction of disability in MS.
• Emerging glymphatic and molecular imaging hold promise for understanding MS pathophysiology and treatment.